Categories: COVID-19HospitalsNews

Media Advisory – Shriners Hospitals for Children – Canada

MONTREAL, Sept. 20, 2022 (GLOBE NEWSWIRE) —

Patients from Shriners Hospitals for Children – Canada meet the Concordia Stingers on the field this

Wednesday September 21
6:20 p.m.
Concordia Stadium, Loyola Campus, Concordia University
7200 Rue Sherbrooke O, Montréal, H4B 1R2

After two years of COVID-19 restrictions, patients of the Canada Shriners Hospitals and the Concordia Stingers players are getting into the spirit of the 2022 Shrine Bowl. This Wednesday, September 21, patients will join the players on the field to share their love of sport despite their medical conditions, and be invited to take photos and get autographs from the Stingers. They will share their stories of training or adapted sports, as well as their passion of pushing themselves beyond their limits, something our patients do every day, whether in sports or daily activities. Patients and athletes will then share a pizza dinner to end this exciting day on a fun note.

The 34th edition of the Shrine Bowl, which will be held on Saturday, October 1, will pit the Concordia Stingers against the Vert & Or of Sherbrooke University. We will let you know all about it soon!

Media representatives are cordially invited to attend both events.

Information 

Laure Moureaux, Communications Advisor, Shriners Hospitals for Children – Canada
Cell: 514-207-2267/Tel: 514-282-7222
lmoureaux@shrinenet.org

Catherine Grace, Public Relations, Concordia University
Tel: 514-848-2424, ext. 3862
catherine.grace@concordia.ca

Staff

Recent Posts

Specialty Medical Partners Announces Participation in the 2025 Bloom Burton & Co. Healthcare Investor Conference

Toronto, Ontario--(Newsfile Corp. - April 15, 2025) - Specialty Medical Partners, We aim to establish…

2 hours ago

Red Light Holland’s Partner FDA-Compliant and DEA-Registered Irvine Labs Receives 2025 Psilocybin DEA Quotas, Including Import Quota

The companies are now moving forward with the import permit application process.Following expected approval of…

3 hours ago

Psyence BioMed Announces USD$500,000 Follow-On Investment in PsyLabs and Global Ibogaine Supply Agreement

New York, New York--(Newsfile Corp. - April 15, 2025) - Psyence Biomedical Ltd. (NASDAQ: PBM)…

3 hours ago

Ezra Appoints Dr. Danna Chung as Chief Medical Officer

Dr. Chung brings expertise in scaling medical teams to Ezra’s mission of making early cancer…

3 hours ago